Oncolytics Biotech
ONCY
#9651
Rank
HK$0.77 B
Marketcap
HK$6.49
Share price
-3.60%
Change (1 day)
-33.33%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of March 2026 : HK$43.06 Million

According to Oncolytics Biotech 's latest financial reports the company has HK$43.06 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$40.47 M-52.94%
2024-12-31HK$86.01 M-58.15%
2023-12-31HK$0.20 B11.09%
2022-12-31HK$0.18 B-26.68%
2021-12-31HK$0.25 B32.96%
2020-12-31HK$0.18 B125%
2019-12-31HK$84.35 M7.09%
2018-12-31HK$78.76 M7.11%
2017-12-31HK$73.53 M-9.75%
2016-12-31HK$81.48 M-44.06%
2015-12-31HK$0.14 B34.69%
2014-12-31HK$0.10 B-45.45%
2013-12-31HK$0.19 B19.5%
2012-12-31HK$0.16 B-37.43%
2011-12-31HK$0.26 B-20.58%
2010-12-31HK$0.33 B32.1%
2009-12-31HK$0.25 B199.78%
2008-12-31HK$84.3 M-57.53%
2007-12-31HK$0.19 B7.74%
2006-12-31HK$0.18 B-31.69%
2005-12-31HK$0.26 B23.02%
2004-12-31HK$0.21 B76.77%
2003-12-31HK$0.12 B201.01%
2002-12-31HK$41.21 M-43.8%
2001-12-31HK$73.32 M-19.99%
2000-12-31HK$91.64 M275.56%
1999-12-31HK$24.4 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eli Lilly
LLY
HK$41.41 B 96,058.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$82.21 B 190,797.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
HK$7.65 B 17,675.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
HK$0.21 B 406.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$29.33 B 68,004.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
HK$0.60 B 1,309.03%๐Ÿ‡บ๐Ÿ‡ธ USA